Rob received extensive training in the molecular mechanisms of endocrinology while completing his Ph.D. (UofA and Harvard Medical School) and Post-Doctoral Fellowships (Hospital for Sick Children, Toronto and IGBMC, Strasbourg France) before plying this skill set in identifying new targets for drug discovery (Sanofi) and leading drug discovery and development projects (Xenon, Neuromed and CDRD). Rob joined forces with Pieter Cullis, David Huntsman, Martin Dawes, Bruce McManus and Jim Russell to form the not for profit Personalized Medicine Initiative (PMI) in 2011 as Co-founder and COO to implement personalized medicine into healthcare practice. A major thrust of this activity has been the establishment of a big data warehouse to collect broad individual Omic data linked with healthcare data for the analysis of molecular and clinical information collected on health and disease patient cohorts to inform basic research directions as well as detection of biomarkers of disease and wellness. The PMI being incubated at UBC is developing a strong track record with twelve new companies formed, 20 major projects initiated and development of an effective Omic, bioinformatic, translational infrastructure and commercialization ecosystem underway. Together with the PMI associated companies and partners, the PMI has raised $19.4M in non-diluted funding and $17.7M in investment for the implementation projects and companies. For pleasure in his spare time, Rob likes to play and manage water polo.